Relationship between lupus nephritis activity and the serum level of soluble VCAM-1

Lupus

Volumn 7, Issue 5, 1998, Pages 347-354

  Ikeda, Y ^a   Fujimoto, T ^a   Ameno, M ^a   Shiiki, H ^a   Dohi, K ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

E selectin; ICAM 1; Lupus nephritis; Soluble adhesion molecule; VCAM 1

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; DNA ANTIBODY; DOUBLE STRANDED DNA; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ARTICLE; BLOOD LEVEL; COMPLEMENT HEMOLYSIS TEST; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HISTOLOGY; HUMAN; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REMISSION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; DISEASE PROGRESSION; E-SELECTIN; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LUPUS NEPHRITIS; MALE; MIDDLE AGED; SOLUBILITY; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0031853020     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120398678920172     Document Type: Article

References (31)

1. Springer TA Adhesion receptors of the immune system. Nature 1990; 346: 425-434.
2. Bruijn JA, Dinklo NJCM. Distinct patterns of expression of intercellular adhesion molecule-1. vascular cell adhesion molecule-1, and endothelial-leukocyte adhesion molecule-1 in renal disease. Lab Invest 1993; 69: 329-335.
3. Mrowka CH, Sieberth HG. Detection of circulating adhesion molecules ICAM-1, VCAM-1 and E-selectin in Wegener's granulomatosis, systemic lupus erythematosus and chronic renal failure. Clin Nephrol 1995; 43: 288-296.
4. Pigott R, Dillon LP, Hemingway IH, Gearing AJH. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun 1992; 187: 584-589.
5. Gearing AJH et al. Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1; pathological significance. Ann NY Acad Sci 1992; 667: 324-331.
6. Rothlein R, Mainolfi EA, Cazjkowski M, Marlin SD. A form of circulating ICAM-1 in human serum. J Immunol 1991; 147: 3788-3793.
7. Wellicome SM et al. Detection of a circulating form of vascular cell adhesion molecule-1: raised levels in rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Immunol 1993; 92: 412-418
8. Newman W et al. Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock J Immunol 1993; 150: 644-654
9. Carson CW et al. Serum ELAM-1 is increased in vasculities, scleroderma, and systemic lupus erythematosus. J Rheumatol 1993; 20: 809-814
10. Machold KP, Kiener HP, Graninger W, Graninger WB. Soluble intercellular adhesion molecule-l(sICAM-1) in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Immunol Immunopathol 1993; 68: 74-78
11. Mason JC, Kapahi P, Haskard DO. Detection of increased levels of circulating intercellular adhesion molecule 1 in some patients with rheumatoid arthritis but not in patients with systemic lupus erythematosus: lack of correlation with levels of circulating vascular cell adhesion molecule 1. Arthritis Rheum 1993; 36: 519-527
12. Seth R, Raymond FD, Makgoba MW. Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders Lancet 1991; 338: 83-84.
13. Tan EM et al The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
14. Bombardier C et al. Derivation of the SLED AI; a disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630-640.
15. Baldwin DS, Gluck MC, Lowenstein J. Lupus nephritis clinical course as related to morphologic forms and their transitions. Am J Med 1977; 62: 12-30.
16. Golbus J, McCune WJ Lupus nephritis, classification, prognosis, immunopathogenesis, and treatment. Rheum Dis Clin North Am 1994; 20: 213-242.
17. Feltkamp T, Kirkwood T, Maini R, Aarden L The first international standard for antibodies to double-stranded DNA. Ann Rheum Disease 1988; 47: 740-746.
18. Mayer MM. Complement and complement fixation. In: Kabat EA, Mayer MM, Heidelberger M (eds). Experimental Immunochemistry. (2nd edn). Thomas: Sprinfield, 1961, pp 133-240
19. Osborn L et al. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 1989; 59: 1203-1211.
20. Janssen BA et al. Correlation of blood levels of soluble vascular cell adhesion molecule-1 with disease activity in systemic lupus erythematosus and vasculitis. Br J Rheumatol 1994; 33: 1112-1116
21. Hay EM, Bacon PA, Gordon C. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. QJ Med 1993; 86: 447-458.
22. Sponk PE et al. Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long-term prospective study. Clin Exp Immunol 1994; 97: 439-444.
23. Bevliacqua MP, Stengelin S, Gimbrone MA Jr, Seed B. Endothelial leukocyte adhesion molecule 1 : an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 1989; 243: 1160-1165.
24. Bevilacqua MP et al Identification of an inducible endothelial-leukocyte adhesion molecule Proc Natl Acad Sci USA 1987; 84: 9238-9242.
25. Iwano M et al Urinary levels of IL-6 in patients with active lupus nephritis. Clin Nephrol 1993; 40: 16-21.
26. Linker-Israeli M et al. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. a putative role in pathogenesis J Immunol 1991; 147: 117-123.
27. Kling E, Bieg S, Boehme M, Scherbaum WA. Circulating intercellular adhesion molecule 1 as a new activity marker in patients with systemic lupus erythematosus. Clin Invest 1993; 71: 299-304.
28. Lhotta K et al. Soluble intercellular adhesion molecule-1 (ICAM-1) in serum and urine: correlation with renal expression of ICAM-1 in patients with kidney disease. Clin Nephrol 1997; 48: 85-91
29. Sfijkakis PP et al. Circulating intercellular adhesion molecule-1 in patients with systemic sclerosis Clin Immunol Immunopathol 1993; 68: 88-92.
30. Chan TM, Yu PM, Tsang KLC, Cheng IKP. Endothelial cell binding by human polyclonal anti-DNA antibodies, relationship to disease activity and endothelial functional alterations. Clin Exp Immunol 1995; 100: 506-513.
31. Meroni PL et al. Anti-endothelial cell antibodies: only for scientists or for clinicians too? Clin Exp Immunol 1996; 104: 199-202